Glial gene–protein networks in neuroinflammation and disease transitions

Neuroinflammatory responses emerge from interacting molecular configurations rather than from uniform activation programs. This review examines how extracellular cues, receptor and sensor systems, intracellular signaling pathways, gene and protein effectors, and reciprocal microglia–astrocyte communication combine to shape glial function across neurological disease. Particular attention is given to nuclear factor kappa B, Janus kinase/signal transducer and activator of transcription 3 (STAT3), transforming growth factor beta, interferon-associated signaling, purinergic receptors, inflammasome pathways, ion and water transport systems, complement, and extracellular matrix regulation. Mechanistic comparisons show that pathway identity alone does not determine biological output: receptor context, interacting molecular partners, glial cell type, signal duration, disease phase, and local tissue environment alter whether related regulatory modules support surveillance, clearance, repair-associated remodeling, persistent inflammation, or tumor-associated niche organization. These principles are compared across Alzheimer’s disease, Parkinson’s disease, stroke, and glioblastoma, revealing substantial differences in initiating signals, temporal organization, cellular interactions, and evidentiary strength. Transcriptomic, proteomic, cerebrospinal fluid, blood, and spatial profiling further demonstrate that measurable glial states require interpretation by biological source and validation level. Experimental interventions targeting NLR family pyrin domain-containing protein 3, astrocytic water-channel systems, microglial populations, STAT3-associated signaling, and glioblastoma microenvironmental interactions illustrate that therapeutic effects depend not only on the molecular target but also on the glial and disease configuration in which it operates. A configuration-based interpretation of glial gene–protein networks therefore provides a mechanistic basis for comparing disease states, evaluating biomarkers, and matching molecular interventions to biologically defined therapeutic windows.

Authors

Publication Details

Journal
Gene & Protein in Disease
Published
2026-11-17
DOI
https://doi.org/10.36922/gpd026190014
Primary Topic
Neuroinflammation and Neurodegeneration Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Glial gene–protein networks in neuroinflammation and disease transitions

Moawiah M. Naffaa
3 links
Gene & Protein in Disease
Neuroinflammation and Neurodegeneration Mechanisms
article

Glial gene–protein networks in neuroinflammation and disease transitions

Moawiah M. Naffaa
article en

Abstract

Neuroinflammatory responses emerge from interacting molecular configurations rather than from uniform activation programs. This review examines how extracellular cues, receptor and sensor systems, intracellular signaling pathways, gene and protein effectors, and reciprocal microglia–astrocyte communication combine to shape glial function across neurological disease. Particular attention is given to nuclear factor kappa B, Janus kinase/signal transducer and activator of transcription 3 (STAT3), transforming growth factor beta, interferon-associated signaling, purinergic receptors, inflammasome pathways, ion and water transport systems, complement, and extracellular matrix regulation. Mechanistic comparisons show that pathway identity alone does not determine biological output: receptor context, interacting molecular partners, glial cell type, signal duration, disease phase, and local tissue environment alter whether related regulatory modules support surveillance, clearance, repair-associated remodeling, persistent inflammation, or tumor-associated niche organization. These principles are compared across Alzheimer’s disease, Parkinson’s disease, stroke, and glioblastoma, revealing substantial differences in initiating signals, temporal organization, cellular interactions, and evidentiary strength. Transcriptomic, proteomic, cerebrospinal fluid, blood, and spatial profiling further demonstrate that measurable glial states require interpretation by biological source and validation level. Experimental interventions targeting NLR family pyrin domain-containing protein 3, astrocytic water-channel systems, microglial populations, STAT3-associated signaling, and glioblastoma microenvironmental interactions illustrate that therapeutic effects depend not only on the molecular target but also on the glial and disease configuration in which it operates. A configuration-based interpretation of glial gene–protein networks therefore provides a mechanistic basis for comparing disease states, evaluating biomarkers, and matching molecular interventions to biologically defined therapeutic windows.

Gene & Protein in DiseaseVol. 0(0)
Good health and well-being
Neuroinflammation and Neurodegeneration Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon